Quince Therapeutics Inc (QNCX)
0.95
+0.03
(+3.26%)
USD |
NASDAQ |
May 10, 16:00
0.9582
+0.01
(+0.86%)
After-Hours: 20:00
Quince Therapeutics Shareholders Equity (Quarterly): 85.08M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.08M |
| September 30, 2023 | 83.13M |
| June 30, 2023 | 86.88M |
| March 31, 2023 | 90.20M |
| December 31, 2022 | 100.59M |
| September 30, 2022 | 104.53M |
| June 30, 2022 | 111.53M |
| March 31, 2022 | 106.38M |
| December 31, 2021 | 118.59M |
| September 30, 2021 | 132.65M |
| June 30, 2021 | 142.08M |
| Date | Value |
|---|---|
| March 31, 2021 | 156.48M |
| December 31, 2020 | 172.26M |
| September 30, 2020 | 188.01M |
| June 30, 2020 | 205.47M |
| March 31, 2020 | 218.04M |
| December 31, 2019 | 115.48M |
| September 30, 2019 | 127.29M |
| June 30, 2019 | 136.22M |
| March 31, 2019 | -38.03M |
| December 31, 2018 | -32.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
83.13M
Minimum
Sep 2023
218.04M
Maximum
Mar 2020
130.57M
Average
118.59M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 167.90M |
| Total Liabilities (Quarterly) | 82.82M |